Cargando…
Pathobiology of Hemangiosarcoma in Dogs: Research Advances and Future Perspectives
Hemangiosarcoma (HSA) is an aggressive and common cancer in dogs. While cutaneous masses are often treatable by tumor excision, visceral tumors are almost always incurable. Treatment advances for this disease have been limited due to a poor understanding of the overall tumor biology. Based upon its...
Autores principales: | Kim, Jong-Hyuk, Graef, Ashley J., Dickerson, Erin B., Modiano, Jaime F. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5644642/ https://www.ncbi.nlm.nih.gov/pubmed/29061949 http://dx.doi.org/10.3390/vetsci2040388 |
Ejemplares similares
-
Constitutive expression and roles of interleukin-8 in canine hemangiosarcoma
por: Kim, Jong-Hyuk, et al.
Publicado: (2013) -
Hemangiosarcoma and its cancer stem cell sub-population are effectively killed by a toxin targeted through epidermal growth factor and urokinase receptors
por: Schappa, Jill T, et al.
Publicado: (2013) -
Cutaneous Hemangiosarcoma in a Dog
por: Tsuji, Naho, et al.
Publicado: (2013) -
Hyperferritinemia in Dogs with Splenic Hemangiosarcoma
por: CHIKAZAWA, Seishiro, et al.
Publicado: (2013) -
Primary intrapelvic hemangiosarcoma in a dog
por: YOO, Saejong, et al.
Publicado: (2016)